NPI: 1518921527 · STERLING, VA 20164 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,424 | $125K |
| 2019 | 16,185 | $125K |
| 2020 | 1,950 | $69K |
| 2021 | 6,553 | $221K |
| 2022 | 4,548 | $219K |
| 2023 | 343 | $30K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 14,981 | 970 | $746K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,019 | 713 | $34K |
| J1756 | Injection, iron sucrose, 1 mg | 2,658 | 532 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,759 | 875 | $2K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 19 | 12 | $1K |
| 83540 | 406 | 213 | $433.80 | |
| 83970 | 365 | 183 | $120.57 | |
| 83550 | 367 | 193 | $36.80 | |
| 82728 | 338 | 179 | $24.97 | |
| G0008 | Administration of influenza virus vaccine | 23 | 15 | $6.59 |
| A4657 | Syringe, with or without needle, each | 1,953 | 811 | $5.47 |
| 85041 | 493 | 275 | $1.35 | |
| 85048 | 481 | 268 | $1.17 | |
| 82746 | 55 | 27 | $0.00 | |
| 82607 | 55 | 27 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 31 | 14 | $0.00 |